| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 06/13/2007 | EP1795195A1 New prazole compound and the use thereof |
| 06/13/2007 | EP1795192A2 1-Substituted imidazole derivatives as nos inhibitors |
| 06/13/2007 | EP1794150A1 Benzimidazole derivatives and their use as cannabinoid receptor ligands I |
| 06/13/2007 | EP1794147A1 Compounds |
| 06/13/2007 | EP1794123A1 3-spiro-indolin-2-one derivatives as vasopressin receptor ligand |
| 06/13/2007 | EP1793859A2 Methods of healing wounds by administering human il-18 |
| 06/13/2007 | EP1793835A2 SMALL INTERFERING RNAs THAT EFFICIENTLY INHIBIT VIRAL GENE EXPRESSION AND METHODS OF USE THEREOF |
| 06/13/2007 | EP1641784B1 4-(aminomethyl)-piperidine benzamides as 5ht4 -antagonists |
| 06/13/2007 | EP1499623B1 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-¬(2-methyl-1h-imidazol-1-yl)methyl|-4h-carbazol-4-one |
| 06/13/2007 | EP1490065B1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors |
| 06/13/2007 | EP1456219B1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2a receptor agonist |
| 06/13/2007 | EP1455810B1 Pharmaceutical formulation comprising cyclosporin and use thereof |
| 06/13/2007 | EP1353726B1 Rehydration composition |
| 06/13/2007 | EP1337512B1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists |
| 06/13/2007 | EP1302542B1 Novel physiologically active peptide and use thereof |
| 06/13/2007 | EP1230349B1 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 06/13/2007 | EP1214292B1 Tyrosine derivatives |
| 06/13/2007 | EP1176870B1 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 06/13/2007 | EP1140969B1 Connective tissue growth factor fragments and methods and uses thereof |
| 06/13/2007 | EP1069909B1 Conjugate vaccines for the prevention of dental caries |
| 06/13/2007 | EP0954330B1 Intestinal trefoil proteins |
| 06/13/2007 | EP0862630B1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 06/13/2007 | CN1981028A Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries |
| 06/13/2007 | CN1980683A Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation |
| 06/13/2007 | CN1980679A Glycyrrhizin-containing suppository compositions for rectal infusion |
| 06/13/2007 | CN1980579A Prebiotic preparation |
| 06/13/2007 | CN1977966A Ointment capable of expelling wind and eliminating stasis |
| 06/13/2007 | CN1977957A Method for preparing toothache drops |
| 06/13/2007 | CN1977946A Health care granule for computer operator |
| 06/13/2007 | CN1977944A Red ginseng and lilyturf root soft capsule and its preparing method |
| 06/13/2007 | CN1977942A Medicinal composition for treating constipation |
| 06/13/2007 | CN1977936A Chinese medicine compound preparation for treating male-female deficiency syndrome and its preparing method |
| 06/13/2007 | CN1977931A Chinese medicine for treating stomach disease and its preparing method |
| 06/13/2007 | CN1977924A Medicine for anti-liver fibrosis |
| 06/13/2007 | CN1977922A Chinese medicine gargle for treating erosive oral mocositis, and its preparing method |
| 06/13/2007 | CN1977921A Chinese medicine preparation for treating hepatitis and anti-fulminant hepatitis, and its preparing method and use |
| 06/13/2007 | CN1977917A Wuzhi dispersible table and its production method |
| 06/13/2007 | CN1977897A Health care medicine |
| 06/13/2007 | CN1977892A Method for regulating baicalin and baicalein ratio in scutellariae root extract |
| 06/13/2007 | CN1977889A Medicinal composition of astragalus, salvia miltrorrhiza and oxymatrine, and its preparing method |
| 06/13/2007 | CN1977888A Medicinal composition of baicalin, ganoderma lucidum and salvia miltrorrhiza |
| 06/13/2007 | CN1977887A Medicinal composition for treating hepatitis |
| 06/13/2007 | CN1977886A Medicinal composition of oxymatrine, ganoderma lucidum and astragalus |
| 06/13/2007 | CN1977885A Antihepatitis medicinal composition |
| 06/13/2007 | CN1977882A Medicinal composition of astragalus, hypericum japonicum thunb. and tiopronin, and its preparing method |
| 06/13/2007 | CN1977878A Chinese medicine composition and its use |
| 06/13/2007 | CN1977875A Chinese medicine compound preparation for anti hepatitis |
| 06/13/2007 | CN1977873A Epimedium total flavone extracting process |
| 06/13/2007 | CN1977872A Function of PES for preventing and treating hyper lipidemia and fat liver |
| 06/13/2007 | CN1977865A Method for preparing domestic fungus health care oral liquid |
| 06/13/2007 | CN1977852A Medicinal composition containing stilbene total glycoside and its use for pharmaceutical treating hepatitis B |
| 06/13/2007 | CN1977814A Plant eye cream function lotion |
| 06/13/2007 | CN1977667A Method for preparing health-care nutrient powder |
| 06/13/2007 | CN1977624A Mint tea |
| 06/13/2007 | CN1321131C Pig Ghrelin derivative, its encoding gene and application |
| 06/13/2007 | CN1321115C Piperazine derivatives for use as CCR-3 receptor antagonists in the treatment of asthma |
| 06/13/2007 | CN1320921C Small injection of glossy privet fruit |
| 06/13/2007 | CN1320920C Freeze-dried powder injection of glossy |
| 06/13/2007 | CN1320917C Dripping pills of 'Xiao Chaihu' |
| 06/13/2007 | CN1320906C Yin-nourishing and Yiwei capsules and preparation thereof |
| 06/13/2007 | CN1320899C Medicine for treating ulcer haemorrhage |
| 06/13/2007 | CN1320891C Extractive of Japanese St.Johnswort and preparation method and application |
| 06/13/2007 | CN1320884C Muscle strong agent and anti-inflammatory agent |
| 06/13/2007 | CN1320881C Globelet pill for treating acute or chronic hepatitis |
| 06/13/2007 | CN1320880C Improved formulation for topical non-invasive application in vivo |
| 06/12/2007 | US7230106 Process for the preparation of inhibitors of macrophage migration inhibitory factor |
| 06/12/2007 | US7230103 Substituted 3,4-dihydropyrido[1,2-a]pyrimidines |
| 06/12/2007 | US7230078 for prophylaxis, prevention, treatment or therapy of inflammatory conditions or allergic reactions in a mammal; binds bacterial lipopeptide |
| 06/12/2007 | US7230031 Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 06/12/2007 | US7230030 Ether, alcohol, ester, carbamate or carbonate,sulfamate or silanol substituted-3,3-diphenylpropylamine derivatives; prodrugs of antimuscarinic agents with superior pharmacokinetic properties |
| 06/12/2007 | US7230019 As neuroprotective agents in the therapy of neuronal disorders of the central and peripheral nervous systems |
| 06/12/2007 | US7230018 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 06/12/2007 | US7229997 1-(pyridin-2-yl)-piperazine derivatives; serotonin receptor antagonists |
| 06/12/2007 | US7229994 Analgesics; anxiolytic agents; gastrointestinal disorders |
| 06/12/2007 | US7229987 Oxazoles with one or more tertiary amine groups and phenyl groups, e.g., 1-{4-[2-(Benzofuran-2-ylmethoxymethyl)-oxazol-5-yl]-phenyl}-3-(2-dimethylamino-ethyl)-urea and -(3-{4-[2-(2-Phenoxy-ethylsulfanylmethyl)-oxazol-5-yl]-phenoxy}-propyl)-azepine; treating obesity and related diseases, e.g., diabetes |
| 06/12/2007 | US7229755 Isolating a biological specimen from a human; testing the specimen for an alteration in a human MSH2 nucleotide sequence or its expression product; comparing the results obtained with the results obtained from a wild type control |
| 06/12/2007 | US7229646 Methods and compositions for modulating immune response and for the treatment of inflammatory disease |
| 06/12/2007 | US7229623 Her-2/neu fusion proteins |
| 06/12/2007 | CA2392674C Pyrazoloquinolinone derivatives as protein kinase c inhibitors |
| 06/12/2007 | CA2246235C Colonic delivery of nicotine to treat inflammatory bowel disease |
| 06/07/2007 | WO2007065172A1 Methods for altering stool quality and/or stool frequency |
| 06/07/2007 | WO2007064755A2 Treatment of xerostomia with a sulfur-containing antioxidant |
| 06/07/2007 | WO2007064664A2 Prostaglandin ep4 agonists for the treatment of gastric conditions |
| 06/07/2007 | WO2007064505A1 Confectionary compositions with magnolia bark extract |
| 06/07/2007 | WO2007064274A1 Oral pharmaceutical dosage form comprising as active ingredients a proton pump inhibitor together with acetyl salicyclic acid |
| 06/07/2007 | WO2007063868A1 Arylmethylene urea derivative and use thereof |
| 06/07/2007 | WO2007063159A1 Rectal use of a sodium chloride solution as an intestinal cleanser |
| 06/07/2007 | WO2007063086A1 Novel nk1 and nk2 antagonists |
| 06/07/2007 | WO2007062837A2 Use of a 5-ht4 agonist for the treatment of irritable bowel syndrome characterized by mixed or alternating bowel habits |
| 06/07/2007 | WO2007062595A1 Bismuth hyaluronate, the preparation method and the use theirof |
| 06/07/2007 | WO2007062469A1 Methods and compositions for preventing and/or treating pancreatitis |
| 06/07/2007 | WO2007043710A9 Novel dihydropseudoerythromycin derivatives |
| 06/07/2007 | WO2007025977A3 Anti-tnf alpha producing lactic acid bacteria for the treatment of chronic enterocolitis |
| 06/07/2007 | WO2006074127A3 Biomarkers for identifying efficacy of tegaserod in patients with chronic constipation |
| 06/07/2007 | WO2006049564A8 New modified release pellet formulations for proton pump inhibitors |
| 06/07/2007 | US20070129420 New pyrrolidinium derivatives |
| 06/07/2007 | US20070129398 3(R)-1-Phenethyl-(9[H]-xanthene-9-carbonyloxy)-1-azoniabicyclo[2.2.2] octane quaternary salt with a mono- or polyvalent anion; antimuscarinic agents used to treat chronic obstructive pulmonary disease, chronic bronchitis, bronchial hyperreactivity, asthma, or rhinitis |
| 06/07/2007 | US20070129373 Phthalazinone-piperidino-derivatives as PDE4 inhibitors |
| 06/07/2007 | US20070129348 Receptor antagonist |
| 06/07/2007 | US20070129316 antidepressant comprising at least one of scymnol or scymnol esters, soybean isoflavones and soybean isoflavone glycosides, curcumin, and or cholic acid; herbal medicine |